Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0015967
Disease: Fever
Fever
0.010 GeneticVariation phenotype BEFREE ASL experiments with standard parameters (B<sub>1ave</sub> = 5 µT, T<sub>acq</sub> = 4 min, labeling with volume coil) lead to a brain temperature increase due to RF of 0.72 ± 0.46 K for pCASL and 0.25 ± 0.17 K for CASL. 31429990 2020
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.010 Biomarker disease BEFREE In the mice, knocking-down both AURKA and NEDD9 could alleviate the OA development significantly. 31357086 2019
Secondary malignant neoplasm of liver
0.010 AlteredExpression disease BEFREE No significant differences in survival rates were identified regarding the expression of E-cadherin and NEDD9 in the primary tumor, metastatic lymph nodes and liver metastases. 30854064 2019
Secondary malignant neoplasm of colon and/or rectum
0.010 AlteredExpression disease BEFREE E-cadherin and NEDD9 expression in primary colorectal cancer, metastatic lymph nodes and liver metastases. 30854064 2019
CUI: C0003872
Disease: Arthritis, Psoriatic
Arthritis, Psoriatic
0.010 Biomarker disease BEFREE Our studies revealed significant inhibition of Rac1/NEDD9 pathway in PA treated cells thereby providing a molecular basis of the inhibitory effect of PA on PCa cell migration and invasion. 29436741 2018
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.010 Biomarker group BEFREE Furthermore, <i>NEDD9</i> ablation or inhibition prevented fibrotic vascular remodeling and pulmonary hypertension in animal models of PAH in vivo. 29899023 2018
CUI: C0029925
Disease: Ovarian Carcinoma
Ovarian Carcinoma
0.010 AlteredExpression disease BEFREE Collectively, these data suggest that tumor cell-intrinsic Nedd9 expression promotes OC development and progression by broad induction of oncogenic protein signaling and stem/mesenchymal gene expression. 29773902 2018
CUI: C0206687
Disease: Carcinoma, Endometrioid
Carcinoma, Endometrioid
0.010 Biomarker disease BEFREE This study aimed to investigate the role of NEDD9 (neural precursor cell expressed developmentally down-regulated 9), BCAR1/P130CAS (BCAR1/P130 Crk-associated substrate) and paxillin in predicting the prognosis of endometrioid adenocarcinoma (EA), so as to guild the nursing of EA. 29364471 2018
CUI: C0339143
Disease: Thyroid associated opthalmopathies
Thyroid associated opthalmopathies
0.010 Biomarker disease BEFREE Patients were divided into inactive TED (CAS 0-1; 20 eyes from 11 patients) and active TED (CAS 2-3, 11 eyes from 6 patients) groups. 29649988 2018
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.010 AlteredExpression disease BEFREE Collectively, these data suggest that tumor cell-intrinsic Nedd9 expression promotes OC development and progression by broad induction of oncogenic protein signaling and stem/mesenchymal gene expression. 29773902 2018
CUI: C1569637
Disease: Adenocarcinoma, Endometrioid
Adenocarcinoma, Endometrioid
0.010 Biomarker disease BEFREE This study aimed to investigate the role of NEDD9 (neural precursor cell expressed developmentally down-regulated 9), BCAR1/P130CAS (BCAR1/P130 Crk-associated substrate) and paxillin in predicting the prognosis of endometrioid adenocarcinoma (EA), so as to guild the nursing of EA. 29364471 2018
Carcinoma of urinary bladder, invasive
0.010 Biomarker disease BEFREE NEDD9 protein tissue marker could be used as a predictive marker for BCG response in nonmuscle invasive bladder cancer with reasonable sensitivity and specificity. 29519561 2018
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 AlteredExpression disease BEFREE Expression of NEDD9 was significantly increased in PDAC (strong expression in 78.7% of cases and moderate in 21.3%) and reduced in normal pancreatic tissue (strong positivity in 45.9% of cases, moderate in 31.1%, and weak in 23%). 29924959 2018
CUI: C2973725
Disease: Pulmonary arterial hypertension
Pulmonary arterial hypertension
0.010 Biomarker disease BEFREE NEDD9 targets <i>COL3A1</i> to promote endothelial fibrosis and pulmonary arterial hypertension. 29899023 2018
Idiopathic pulmonary arterial hypertension
0.010 Biomarker disease BEFREE These data identify a critical TGF-β-independent posttranslational modification that impairs SMAD3-NEDD9 binding in HPAECs to modulate vascular fibrosis and promote PAH. 29899023 2018
CUI: C0013371
Disease: Shigella Infections
Shigella Infections
0.010 Biomarker group BEFREE CRISPR-associated protein genes cas1 and cas2 in Shigella were detected by polymerase chain reaction (PCR), and the PCR products were sequenced and compared. 28207509 2017
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 Biomarker disease BEFREE These results present a SOX9/SOX10-NEDD9/DLC1-RHOA regulatory axis to govern NCC migratory polarization. 29084958 2017
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 Biomarker disease BEFREE These results present a SOX9/SOX10-NEDD9/DLC1-RHOA regulatory axis to govern NCC migratory polarization. 29084958 2017
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 Biomarker disease BEFREE These results present a SOX9/SOX10-NEDD9/DLC1-RHOA regulatory axis to govern NCC migratory polarization. 29084958 2017
CUI: C1861305
Disease: TARSAL-CARPAL COALITION SYNDROME
TARSAL-CARPAL COALITION SYNDROME
0.010 Biomarker disease BEFREE <i>Methods.</i> To assess their prognostic role; NEDD9 and p38 protein were evaluated in sections from 50 paraffin blocks of TCC. 28194179 2017
CUI: C0009447
Disease: Common Variable Immunodeficiency
Common Variable Immunodeficiency
0.010 Biomarker disease BEFREE Given that residual p105 and p50—translated from the non-mutated alleles—were normal, and altered p50 proteins were absent, we conclude that the CVID phenotype in these families is caused by NF-κB1 p50 haploinsufficiency. 26279205 2015
CUI: C0022680
Disease: Polycystic Kidney Diseases
Polycystic Kidney Diseases
0.010 Biomarker group BEFREE Finally, we briefly discuss emerging evidence supporting involvement of NEDD9 in additional pathological conditions, including stroke and polycystic kidney disease. 25967390 2015
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE Finally, we briefly discuss emerging evidence supporting involvement of NEDD9 in additional pathological conditions, including stroke and polycystic kidney disease. 25967390 2015
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.010 Biomarker disease BEFREE NEDD9 targeting is therapeutically viable as it does not stimulate adaptive changes in glioma and neuroblastoma invasion. 24337070 2014
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.010 AlteredExpression disease BEFREE Results suggested that NEDD9 was overexpressed in EOC specimens compared with noninvasive epithelial ovarian tumors and normal ovarian specimens. 24439227 2014